March 11, 2026. 392 items curated for clinical relevance.
Above Threshold
Alabama Medical Cannabis Sales Gear for Spring 2026 Launch
Summary
Alabama’s medical cannabis program is preparing to begin retail sales in spring 2026, providing clinicians with a new legal treatment option for eligible patients.
Cannabis compounds CBD and CBG may help reverse fatty liver disease, study finds
Summary
Cannabis cannabinoids CBD and CBG show potential therapeutic effects against fatty liver disease, offering clinicians new evidence-based options for treating this prevalent hepatic condition.
From Billion-Dollar Hemp Drinks to FDA Cease-and-Desist Letters: The Cannabis Industry’s …
Summary
This article examines regulatory enforcement actions against cannabis beverage manufacturers, highlighting the gap between commercial growth and FDA compliance—critical for clinicians advising patients on product safety and legality.
Cannabis Compounds CBD and CBG Show Promise in Reducing Liver Fat and Improving …
Summary
Cannabinoids CBD and CBG demonstrate potential therapeutic effects on hepatic steatosis, offering clinicians evidence-based compounds for managing liver fat accumulation in patients.
New Cannabis Group Will Help Ground Policy In Science And Patient Experience As …
I’d be happy to help, but the article summary you provided is incomplete—it cuts off after “As…”
Could you please share the full title and summary so I can write an accurate one-sentence description for cannabis clinicians?
New Top Cannabis Regulator Sets Priorities In First Board Meeting
Summary
A newly appointed cannabis regulator outlined their priorities at their inaugural board meeting, informing clinical practice standards and compliance requirements for cannabis-prescribing healthcare providers.
Brazil’s Cannabis Crossroads: New Rules, Old Truths, and the Road Ahead
Brazil’s Cannabis Regulatory Framework and Clinical Implications
Brazil’s evolving cannabis regulations establish new legal pathways for medical use while addressing longstanding implementation challenges relevant to clinical practice.
2 Greater Cincinnati breweries file lawsuit over Ohio ban on THC beverages – WLWT
Summary
Two Cincinnati breweries are challenging Ohio’s legal prohibition on THC-infused beverages, raising regulatory and compliance issues relevant to cannabis practitioners managing patient access to alternative consumption methods.
New Ohio law means THC-infused drinks won’t be available on many store shelves – WTVG
Summary
Ohio enacted legislation restricting THC-infused beverage availability in retail settings, affecting patient access to alternative cannabis consumption methods and requiring clinicians to update counseling on product availability.
Lawmakers strike down bill capping THC levels in Oregon’s cannabis edibles – Yahoo
Summary
Oregon lawmakers rejected legislation that would have limited THC potency in cannabis edibles, affecting product regulation and clinical considerations for patient dosing and safety protocols.
Attempt to limit potency of THC in marijuana edibles fails at Oregon Legislature
Summary
Oregon legislators rejected a bill to cap THC potency in cannabis edibles, leaving clinicians without regulatory limits on product strength when counseling patients about dosing and safety.
Cannabis Compounds CBD and CBG Slash Liver Fat and Restore Metabolic Health
Summary Sentence
Cannabis compounds CBD and CBG demonstrate potential to reduce hepatic steatosis and improve metabolic markers, relevant for clinicians considering cannabinoid therapeutics in metabolic disease management.
Cannabinoid Oral Mucosal Delivery: Approaches to Formulation, Fabrication, and … – PubMed
Summary
This article examines formulation and fabrication methods for delivering cannabinoids through oral mucosal routes, providing clinicians with evidence-based approaches to optimize cannabinoid bioavailability and clinical efficacy.
Study: CBD-Dominant Cannabis Products Provide Significant Anxiety Relief – NORML
Summary
CBD-dominant cannabis products show clinical efficacy for anxiety treatment, providing evidence-based data relevant to clinician dosing recommendations and patient selection protocols.
Clinical Trial: Cannabis Extracts Significantly Reduce Myofascial Pain – NORML
Summary
A clinical trial demonstrates cannabis extracts effectively reduce myofascial pain, providing evidence-based data for clinicians treating musculoskeletal pain conditions with cannabinoid therapy.
As a Medical Cannabis Patient, I’m Watching This Supreme Court Case Closely
Summary
This article discusses a Supreme Court case relevant to medical cannabis patients and likely addresses legal or regulatory implications that clinicians should monitor for patient care and practice implications.
The Week in Weed: March 2026 | Seyfarth Shaw LLP – JDSupra
Cannabis Article Summary
This article covers cannabis legal and regulatory developments from March 2026, providing clinicians with timely updates on compliance requirements and policy changes affecting clinical practice.
Marijuana gummies sold in Ohio recalled. Why, where they were sold – The Columbus Dispatch
Summary
Marijuana gummies sold in Ohio were recalled, requiring clinicians to monitor patients for potential adverse effects and verify product safety status with dispensaries.
New Group Launches Ahead of Medicare CBD Pilots – Cannabis Wire
Summary
A new organization has formed to prepare for upcoming Medicare-funded cannabidiol pilot programs, which could establish clinical evidence and reimbursement pathways for cannabis in healthcare.
Marijuana Status Based Prohibition Tag Archives – Powers Law Firm PA
Summary
This archive covers legal prohibition frameworks affecting marijuana status, which matters to clinicians for understanding jurisdictional regulations governing patient care and treatment recommendations.
Louisiana lawmaker files bill to legalize recreational marijuana through licensed dispensaries
Summary
Louisiana legislator proposes legalizing recreational marijuana sales via licensed dispensaries, which would expand patient access and establish regulated market structures relevant to clinical practice.
Mom’s homemade medical cannabis recipe now being sold at Georgia dispensaries
Summary
A mother’s homemade medical cannabis formulation has achieved commercial distribution through Georgia dispensaries, demonstrating patient-developed preparations entering regulated market channels.
Ohio THC drink ban draws lawsuit from Cincinnati breweries
Summary
Ohio’s THC beverage prohibition faces legal challenge from breweries, affecting regulatory policy on cannabis-infused drinks that clinicians prescribe or counsel patients about.
Israeli researchers find cannabis compounds could lead to 1st drug for fatty liver disease
Summary
Israeli researchers identified cannabis compounds as potential treatments for fatty liver disease, offering clinicians a new therapeutic avenue for a condition lacking FDA-approved medications.
Virginia adult-use sales bills pass both chambers, head to conference committee! – Blog
Summary
Virginia’s adult-use cannabis sales bills passed both legislative chambers and advance to conference committee, establishing regulatory framework that clinicians must understand for patient counseling and legal practice considerations.
Study highlights pros, cons of medical marijuana as its future in Tennessee remains unknown
Summary
A study examines medical marijuana’s therapeutic benefits and risks, with implications for clinical practice as Tennessee’s regulatory status remains undetermined.
2026 Utah legislature on cannabis, psychedelics and kratom – Fox 13
Cannabis Clinician Summary
The 2026 Utah legislature addresses regulatory developments in cannabis, psychedelics, and kratom—relevant to clinicians for understanding evolving legal frameworks affecting patient treatment options and practice standards.
Oregon Bill To Ban Marijuana Edibles With More Than 10 Milligrams Of THC Fails
Oregon Bill To Ban Marijuana Edibles With More Than 10 Milligrams Of THC Fails
**Summary:** A proposed Oregon regulation limiting THC content in cannabis edibles to 10mg did not pass, maintaining current higher dosing options for patient access and clinical recommendations.
Georgia bill could limit probable cause for smell of marijuana, cannabis, or hemp – YouTube
Georgia legislation proposing to reduce marijuana odor as standalone probable cause for searches, directly affecting clinician documentation and patient legal protections in medical cannabis cases.
Study reveals cannabis compounds reduce threat of fatty liver disease | Health
Study Summary for Cannabis Clinicians
Cannabis compounds show potential to reduce fatty liver disease risk, providing clinical evidence relevant to cannabis safety profiles and patient treatment considerations.
(Word count: 24)
Prescription Cannabidiol CBD Oil Market to Hit US$ 190.9 Billion by 2032 at 23.48% CAGR
Summary Sentence
Market analysis projects prescription CBD oil will reach $190.9 billion by 2032 with 23.48% annual growth, indicating significant expansion of pharmaceutical cannabis products clinicians may prescribe.
I’m unable to write this summary because no article content was provided—only a title and empty summary field. Please share the article text so I can create an accurate, clinically-relevant one-sentence description.
InMed Pharmaceuticals Shifts Focus to Therapeutic Programs, Ends BayMedica’s Non …
Summary
InMed Pharmaceuticals discontinued its non-therapeutic cannabis operations through BayMedica, refocusing on pharmaceutical development—relevant to clinicians tracking company consolidation and therapeutic cannabinoid research advancement.
Cannabis Extracts Significantly Reduce Myofascial Pain | Trending – Labroots
Summary
Cannabis extracts demonstrate efficacy in reducing myofascial pain, providing clinicians with evidence-based therapeutic options for patients with musculoskeletal pain conditions.
Pediatricians warn about cannabis use disorder, kids’ easy access to the drug – YouTube
Pediatricians highlight cannabis use disorder in children and barriers to prevention, directly relevant to clinicians treating young patients and understanding developmental vulnerabilities to cannabis-related harms.
West Virginia House Passes Bill To Allocate Medical Marijuana Revenue, With Some …
Summary
West Virginia legislators approved a bill directing medical marijuana tax revenue allocation, establishing funding mechanisms relevant to program implementation and clinical operations.
Study highlights positive, negatives of medical marijuana – WKRN News 2
Summary
The article examines research findings on medical marijuana’s therapeutic benefits and adverse effects, providing evidence-based information clinicians need for patient assessment and treatment planning.
The science behind roadside THC testing and diving into SGI’s zero-tolerance policy – Global News
Summary
This article examines roadside THC detection methods and Saskatchewan Government Insurance’s zero-tolerance impaired driving policy, relevant to clinicians managing patient cannabis use and driving safety.
Mom’s homemade medical cannabis recipe now being sold at Georgia dispensaries
Summary
A Georgia mother’s homemade medical cannabis formulation has been commercialized and is now available at state dispensaries, demonstrating patient-derived recipes entering regulated medical markets.
‘Pot for Potholes Act’ aims to legalize marijuana in Tennessee and distribute taxes to repair …
Tennessee “Pot for Potholes Act” Summary
Proposed legislation would legalize marijuana in Tennessee and allocate tax revenue to infrastructure repair, creating potential changes in patient access and clinical practice regulations.
One of Colorado’s Largest Dispensary Chains Agrees to Buyout – Denver Westword
One sentence summary:
A major Colorado dispensary chain agreed to a buyout, representing consolidation in the legal cannabis retail market that affects product availability and clinical recommendations for patients.
Cannabis legalization driving increases in marijuana use among US adults with historically … – MSN
Cannabis Legalization and Adult Use Disparities
Cannabis legalization is associated with increased marijuana use among historically marginalized US adult populations, which clinicians should monitor for health equity implications.
Ohio Department of Commerce recalls certain marijuana gummies lacking THC symbol … – Facebook
Summary
Ohio Department of Commerce issued a recall of marijuana gummies missing required THC labeling symbols, addressing regulatory compliance and product identification standards for clinical practice.
Perceptions of the relative harmfulness of marijuana and alcohol among adults in Oregon.
Summary
This study examines how Oregon adults perceive the health risks of marijuana versus alcohol, providing clinicians with data on patient beliefs that may influence treatment decisions and health counseling.
What’s Really Happening With Cannabis ETF MSOS? – The Dales Report
I cannot write an accurate summary because no article content was provided—only a title and empty summary field. Please share the full article text so I can create a factual one-sentence description relevant to cannabis clinicians.
Study reveals cannabis compounds reduce threat of fatty liver disease – Daily Journal
Summary
Cannabis compounds show potential in reducing fatty liver disease risk, providing clinicians evidence-based information for patient discussions about cannabis use and hepatic health outcomes.
Scientists are raising new concerns about marijuana use in teens – KPBS
Adolescent cannabis use correlates with increased psychiatric risks including psychosis, depression, and anxiety, which is clinically relevant because the developing teenage brain shows heightened vulnerability to these effects.
Clinical Trial: Cannabis Extracts Significantly Reduce Myofascial Pain – NORML
Cannabis Extract Clinical Trial Summary
Sublingual cannabis extracts reduce myofascial pain in temporomandibular disorders, providing clinicians evidence-based data on cannabinoid efficacy for a treatment-resistant condition.
Can the placenta predict schizophrenia risk? Lessons from prenatal cannabis exposure
Summary for Cannabis Clinician
Prenatal THC exposure may disrupt fetal neurodevelopment via the endocannabinoid system; placental biomarkers could identify schizophrenia risk early, informing clinical counseling and pregnancy management.
Scientists are raising new concerns about marijuana use in teens – YouTube
One-Sentence Summary
Adolescent cannabis use poses clinical concerns because THC affects the developing brain through the mid-twenties, with research linking early frequent use to disruption.
A huge study finds a link between cannabis use in teens and psychosis later – NPR
This study documents a causal association between adolescent cannabis use and later psychosis risk, informing clinical assessment and patient counseling regarding age-specific vulnerability.
Teen Cannabis Use Tied to Increase in Serious Mental Illness – Medscape
Adolescent cannabis use increases risk for serious psychiatric conditions like psychosis and bipolar disorder during critical brain development periods—essential knowledge for clinicians managing cannabis patients.
Brain Researchers Finally Know Why Cannabis Use Increases Appetite – The Debrief
Cannabis and Appetite: Clinical Summary
Recent neuroscience research has identified specific brain mechanisms explaining how cannabinoids stimulate appetite, providing clinicians evidence-based understanding for therapeutic applications and patient counseling.
Teen Marijuana Use Doubles Chances of Future Psychotic Disorders, Study Finds
Adolescent cannabis use significantly increases psychotic disorder risk in adulthood; clinicians should screen for early use history when assessing psychiatric symptoms in cannabis patients.
The association between cannabis use and brain reward anticipation: a 12-month … – Nature
This research investigates how cannabis affects brain reward processing, which is clinically important for understanding potential impacts on motivation and pleasure responses in patients.
THC levels in blood and urine are “unreliable” indicators of driving impairment – leafie
THC blood/urine levels poorly correlate with driving impairment due to its lipophilic properties, complicating clinicians’ ability to assess patient safety and provide accurate counseling on cannabis use and driving.
Study Links Prenatal Cannabis Exposure To Schizophrenia – New Telegraph
Prenatal cannabis exposure may alter placental biology in ways associated with increased schizophrenia risk in offspring, relevant to counseling pregnant patients and those planning pregnancy.
The Endocannabinoid System’s Contribution to Placebo Analgesia – bioRxiv
Placebo Analgesia and the Endocannabinoid System
This research demonstrates that placebo pain relief involves endocannabinoid signaling pathways, informing clinicians about neurobiological mechanisms underlying patient expectations in pain management.
Modulating the endocannabinoid system in alcohol use disorder: A translational systematic …
This article examines how targeting endocannabinoid system receptors (CB1/CB2) may therapeutically address neurobiological dysfunction in alcohol use disorder through reward, stress, and impulse control pathways.
Cannabis hyperemesis syndrome is on the rise: What symptoms to watch for – The Hill
Cannabis hyperemesis syndrome causes severe cyclic nausea and vomiting in chronic heavy users, requiring clinicians to recognize and differentiate it from other gastrointestinal conditions for proper diagnosis and management.
Association of Cannabis Use Disorder Versus Other Substance Use Disorders … – Psychiatry Online
This research compares psychiatric outcomes between cannabis use disorder and other substance use disorders, helping clinicians assess the clinical severity and treatment needs of cannabis-dependent patients.
Study Shows Lifetime Cannabis Use Not Associated with Cognitive Decline or Dementia …
Cannabis Clinician Insight
New research indicates lifetime cannabis use shows no association with cognitive decline or dementia in older adults, potentially affecting clinical counseling and risk assessment practices.
Study Finds No Link Between Lifetime Cannabis Use and Cognitive Decline in Older Adults
This study reports that lifetime cannabis use does not accelerate cognitive decline or increase dementia risk in older adults, informing clinical safety assessments for this growing patient population.
Israeli researchers find cannabis compounds could lead to 1st drug for fatty liver disease
Israeli researchers identified cannabinoid compounds effective against non-alcoholic fatty liver disease, a widespread condition currently lacking approved pharmaceutical treatments.
The Coming Divide in Cannabis: Why the U.S. Market Remains Out of Reach for Global Operators
Summary Sentence
The article examines barriers preventing international cannabis companies from entering the U.S. market, relevant to clinicians monitoring industry consolidation affecting product availability and research opportunities.
North Shore Dispensary opens in Duluth’s Lincoln Park – WDIO.com
Summary
A cannabis dispensary opened in Duluth’s Lincoln Park neighborhood, expanding local retail access to cannabis products in the region.
Study reveals cannabis compounds reduce threat of fatty liver disease | Health – News-Topic
Summary for Cannabis Clinicians
Research indicates cannabinoids may reduce non-alcoholic fatty liver disease progression by modulating inflammation and lipid metabolism, potentially expanding therapeutic applications beyond current clinical uses.
Observational study on medical marijuana use seeks Arizona participants – KJZZ
This article describes a research study recruiting Arizona participants to gather real-world evidence on medical cannabis use, which helps clinicians understand effectiveness across diverse patient conditions and consumption methods.
Cannabis compounds show promise in fighting fatty liver disease, scientists say – AZERTAC
Summary for Cannabis Clinician
Preclinical research suggests non-psychoactive cannabinoids (CBD, CBG) may reduce hepatic fat accumulation through endocannabinoid receptor interactions, potentially offering therapeutic targets for fatty liver disease treatment.
A huge study finds a link between cannabis use in teens and psychosis later – KUOW
Longitudinal research demonstrates adolescent cannabis use correlates with increased psychosis risk in adulthood, informing clinician assessment and patient counseling on developmental vulnerability.
Prescribed cannabis and driving behaviours among two samples of people who regularly … – UNSW
This research examines how medical cannabis affects driving safety by investigating psychomotor function and reaction time, essential knowledge for clinicians counseling patients on impairment risks.
Cannabis research: India to start human trials for medicinal marijuana – NewsBytes
India is launching human clinical trials for medicinal cannabis, providing controlled safety and efficacy data essential for evidence-based clinical practice in a previously restricted market.
Cannabis Munchies Driven by Brain Reward Signals | Technology Networks
Summary for Cannabis Clinician
This research identifies the brain reward mechanisms underlying cannabis-induced increased appetite, providing neurological evidence relevant to understanding patient side effects and appetite-related therapeutic applications.
The association between cannabis use and brain reward anticipation: a 12-month … – Nature
This study examines how THC affects reward anticipation in developing brains over 12 months, informing clinicians about cannabis’s neurobiological effects on reward processing.
Screaming, vomiting, and daily weed: The rise of ‘scromiting’ among chronic cannabis users
Cannabinoid hyperemesis syndrome causes severe cyclical nausea and vomiting in chronic heavy cannabis users, requiring clinicians to recognize this condition for accurate diagnosis and appropriate patient management.
Study finds no links between cannabis use and cognitive decline or dementia in older people
This study challenges the assumption that cannabis causes cognitive decline or dementia in older adults, directly informing clinical risk-benefit discussions with aging patients.
Cannabis Use and Brain Aging: What a Major Study Reveals – Born2Invest
Summary for Cannabis Clinicians
This study examines cannabis use’s association with brain aging trajectories using biobank data, providing evidence-based information relevant to clinical assessments of long-term neurological effects in patients.
Cannabis use not linked to cognitive decline or dementia in older adults, study finds – leafie
Summary for Cannabis Clinicians
Recent research indicates cannabis use in older adults is not associated with cognitive decline or dementia risk, potentially informing clinical guidance for this increasingly common patient population.
Study reveals cannabis compounds reduce threat of fatty liver disease | Health – WFMZ.com
Summary for Cannabis Clinician
Preclinical research indicates CBD and THC may reduce hepatic fat accumulation and inflammation in metabolic-associated steatotic liver disease, potentially expanding therapeutic applications.
Placental Changes From Prenatal Cannabis Exposure Could Flag Higher Schizophrenia …
Summary for Cannabis Clinician
Prenatal cannabis exposure causes epigenetic changes in placental tissue linked to schizophrenia risk, providing clinicians a potential biomarker for identifying at-risk pregnancies.
Teens Who Use Cannabis Face Higher Risk Of Mental Disorders, Study Finds – Forbes
Adolescent cannabis use correlates with increased psychiatric disorder risk, emphasizing the developing brain’s vulnerability to THC and the clinical need for early prevention and monitoring in youth populations.
A huge study finds a link between cannabis use in teens and psychosis later – WBAA
Cannabis and Adolescent Psychosis Risk
A large-scale study documents the association between teen cannabis use and later psychosis/depression risk, informing clinical guidance for adolescent patients.
Researcher: Remediated cannabis may still have harmful mold – MJBizDaily
Remediated cannabis may retain undetectable mold harmful to immunocompromised patients, indicating current state testing protocols are insufficient for clinical safety assessment.
So, What Does an Adult at Low Risk of Cannabis Dependence Look Like?
This article examines risk factors for cannabis dependence in adults, helping clinicians identify patients who can safely use cannabis therapeutically with minimal dependence risk.
Cannabis hyperemesis syndrome cases surge in Virginia ERs – YouTube
Cannabis hyperemesis syndrome is increasing in Virginia emergency departments, presenting clinicians with a growing population of frequent users experiencing cyclical vomiting, nausea, and abdominal pain.
Study Finds Veterans With SUD Used Cannabis to Alleviate Pain, Anxiety, and Improve Poor …
Veterans with substance use disorders self-reported using cannabis to manage pain, anxiety, and sleep during treatment, informing clinical understanding of cannabis use patterns in this population.
ARTELO BIOSCIENCES, INC. SEC 10-K Report – TradingView
One-Sentence Summary
Artelo Biosciences’ SEC filing documents pharmaceutical development of targeted cannabinoid therapies for specific medical conditions, relevant to clinicians understanding evidence-based cannabis applications.
Bill to protect Nebraska physicians recommending medical cannabis advances to floor
One Sentence Summary
Nebraska legislation protects physicians from licensing board consequences when recommending medical cannabis, addressing a major barrier that previously deterred qualified doctors from treating eligible patients.
Associations of cannabis use, other substances, and lifestyle choices on anxiety in medical …
This article examines how cannabis interacts with alcohol, caffeine, exercise, and sleep to affect anxiety in medical patients, helping clinicians understand complex factors in treatment planning.
Nebraska bill to protect healthcare practitioners who recommend medical cannabis sails out of com…
Nebraska legislation protects healthcare practitioners recommending medical cannabis, addressing regulatory gaps when voter-approved programs lack safeguards for prescribing physicians.
Major study finds strong link between cannabis, anxiety and depression – Medical Xpress
This article reports observational evidence linking cannabis use to anxiety and depression while noting that causality remains unclear—relevant for clinicians assessing whether cannabis causes, treats, or correlates with these conditions.
Research: Munchies May Aid Those Lacking Appetite – Pullman Today
Cannabis activates CB1 receptors in hunger-regulating brain regions, stimulating appetite—a mechanism clinicians can leverage therapeutically for patients with appetite disorders.
President Biden Signs Historic Cannabis Research Bill – Ganjapreneur
Cannabis Research Bill Summary
President Biden signed federal legislation removing bureaucratic barriers to cannabis research, enabling clinicians to conduct rigorous clinical investigations into cannabinoids more efficiently.
Marijuana Use & Dangers for Adolescents & Young Adults
This article addresses cannabis’s neurological impact on developing brains (adolescence through mid-twenties) and co-occurring cannabis use disorder, critical knowledge for clinicians treating this vulnerable population.
Cannabis hyperemesis syndrome is on the rise: What symptoms to watch for – KGET.com
Cannabis hyperemesis syndrome is a cyclical condition causing severe nausea and vomiting in chronic users, requiring clinicians to recognize this paradoxical adverse effect and adjust treatment accordingly.
Study Published in Pediatrics Finds Infrequent Cannabis Use Can Impact Adolescent …
Adolescent cannabis use at low frequencies (monthly or less) correlates with academic decline and developmental disruption, informing clinician counseling on cannabis risks during critical brain development periods.
Pipeline Progress Drives Investor Focus at Agentix – Ad-hoc-news.de
Summary for Cannabis Clinician
Pharmaceutical companies are developing receptor-targeted cannabinoid drugs instead of whole-plant cannabis, representing a shift toward precision endocannabinoid system modulation with potential clinical implications.
Study: Lifetime Cannabis Use Not Associated with Cognitive Decline or Dementia Risk in … – NORML
Summary for Cannabis Clinician
This article reports longitudinal research findings on lifetime cannabis use and cognitive decline in older adults, providing evidence relevant to patient risk assessment and counseling regarding long-term neurological outcomes.
Study: CBD-Dominant Cannabis Products Provide Significant Anxiety Relief – NORML
CBD-dominant cannabis products show clinical promise for anxiety relief, offering clinicians an evidence-based alternative with potentially fewer psychoactive effects than THC-dominant formulations.
Toronto police shutdown multiple unlicensed cannabis dispensaries – CP24
Toronto police closed unlicensed cannabis dispensaries, relevant to clinicians monitoring unregulated product safety, quality standards, and patient access to legally compliant cannabis sources.
Using cannabis to cut back on alcohol? Your working memory might dictate if it works
Cannabis Article Summary
**One sentence:** This article examines how cannabis use correlates with alcohol reduction, highlighting that individual differences in working memory may influence treatment outcomes for clinicians managing substance use.
Kentucky bill would change how alcohol, cannabis beverages are taxed – WKYT
Summary
Kentucky legislation proposes revising tax structures for alcohol and cannabis beverages, which could affect pricing, accessibility, and patient affordability in clinical cannabis programs.
Mom’s homemade medical cannabis recipe now being sold at Georgia dispensaries – WALB
Summary
A Georgia mother’s homemade medical cannabis formula has achieved commercial dispensary availability, demonstrating patient-developed formulations entering regulated markets and expanding treatment options.
Teens Didn’t Just Discover Weed. So Why Is The Wall St. Journal Acting Like They Did?
Summary
This article critiques media sensationalism around teen cannabis use, relevant to clinicians for understanding how misleading coverage may affect patient education and public health messaging accuracy.
Exploring the Growing Trust in Cannabidiol Oil – The Assam Tribune
Cannabis Clinician Summary
This article discusses increasing confidence in cannabidiol (CBD) oil, which matters to clinicians managing patients exploring non-intoxicating cannabinoid treatments.
Cannabis payouts drop for most Oakland County communities
Summary
Oakland County cannabis tax revenues decreased, affecting funding available to communities—clinicians should monitor how reduced municipal resources may impact local cannabis regulation and patient access services.
New Cannabis Dispensary Opens On Route 22 In Somerville | Bridgewater, NJ Patch
Summary
A cannabis dispensary opened on Route 22 in Somerville, expanding retail access in the New Jersey area—relevant for clinicians tracking patient convenience and local market availability.
Cannabis use by teenagers doubles their risk of developing psychotic and bipolar disorders
Summary
Cannabis use in adolescence significantly increases psychiatric disorder risk; clinicians must assess developmental timing and mental health history when treating teenage patients.
Pediatricians warn about cannabis use disorder, kids’ easy access to the drug
Summary
Pediatricians document cannabis use disorder in children and identify accessibility barriers, providing clinicians with epidemiological data on youth substance use patterns and clinical management implications.
Teen Cannabis Use May Double Your Risk of Psychosis and Bipolar
This article examines the link between teen cannabis use and increased risk of psychosis and bipolar disorder, which is critical for clinicians assessing psychiatric vulnerability in adolescent patients.
Can You Drive the Next Morning After Weed? Study Finds No Significant Impairment 12–15 …
This article examines next-day driving safety after cannabis use, addressing a key clinical concern for practitioners counseling patients about impairment duration and safe driving timelines.
Medicare may soon cover certain cannabis medications for seniors – MSU Denver RED
Medicare’s potential coverage of cannabis-based medications for seniors addresses therapeutic needs in chronic pain, sleep disorders, and neuropathic conditions, expanding treatment options for older adult patients.
Placenta May Hide Early Warning Signs of Schizophrenia Risk – ScienceAlert
Clinician Summary
Prenatal THC exposure may create detectable placental biomarkers associated with schizophrenia risk, highlighting the placenta’s role in identifying vulnerable pregnancies and informing clinical counseling.
Bridging the Gap: Medical Cannabis, Regulators, and the Reality of Clinical Accountability
Medical Cannabis Regulatory Standards
This article explains that cannabis-prescribing physicians must meet the same clinical documentation, reasoning, and patient safety standards as other medical practitioners.
Cannabis use, anxiety and depression are all on the rise in Canada: study – CTV News
Canadian research documents concurrent increases in cannabis use and anxiety/depression diagnoses, prompting clinicians to examine potential associations between cannabis consumption and mental health outcomes.
A Prescription Digital Therapeutic Framework for Enhancing Medical Cannabis Care
This article examines how digital therapeutic tools can standardize cannabis treatment through outcome measurement, personalized dosing, and accountability—essential for evidence-based clinical practice.
Ananda Pharma to Begin Dosing in NHS-Backed CBD Endometriosis Trial
Summary for Cannabis Clinician
An NHS-backed trial will test CBD’s efficacy for endometriosis-related pelvic pain, potentially offering an evidence-based alternative to hormonal and surgical treatments for this prevalent condition.
Washington Senators Approve Bill To Let Terminally Ill Patients Use Medical Cannabis In Hospitals
Washington State legislation permits terminally ill patients to use medical cannabis in hospitals, resolving conflict between state cannabis law and facility policies that previously prohibited use.
Natural Neuroprotection: Exploring the Potential of Non-Psychoactive Cannabinoids
Clinical Summary
Non-psychoactive cannabinoids (CBD, CBG, CBDV) modulate neuroinflammation and oxidative stress through endocannabinoid system pathways, offering potential therapeutic mechanisms for neurodegenerative disease management without psychoactive effects.
America Doesn’t Have A ‘Marijuana Problem,’ As NYT Claims—It Has a Cannabis Education …
This article examines gaps in medical education and research regarding cannabis, arguing that clinical knowledge deficits—not the plant itself—create healthcare challenges for practitioners.
Are My THC Gummies Going Away? – Science Friday
Summary for Cannabis Clinician
The article examines federal regulatory uncertainty around hemp-derived THC gummies, which patients currently use clinically and that could be restricted if lawmakers close the 2018 Farm Bill loophole.
House panel approves proposed medical cannabis law – POLITIKO
The Philippine House is advancing medical cannabis legislation to establish research infrastructure and regulated patient access, directly impacting clinical practice frameworks in the region.
What effects does THC have on youth who dabble? – YouTube
Cannabis article – one-sentence summary
This article examines THC’s effects on adolescent brain development, specifically how exposure impacts the prefrontal cortex and limbic system during critical maturation periods—essential knowledge for clinicians treating young cannabis users.
Tennessee sisters fear new hemp law as CBD oils become harder to access – YouTube
Tennessee sisters fear new hemp law as CBD oils become harder to access
This article documents how restrictive hemp legislation impacts patients with dystonia who rely on full-spectrum CBD for symptom management.
“Mother of Cannabinoids”: The Rising Potential of CBG and CBG-A – Cannabis Health News
Summary for Cannabis Clinician
CBG and CBGA are emerging cannabinoids with preliminary research into anxiety reduction, memory enhancement, and anti-cancer potential, warranting clinical attention as alternative therapeutic compounds.
Ghana launches medicinal cannabis programme under strict regulation
Ghana’s medicinal cannabis program establishes West Africa’s first formal regulatory framework for cannabis-based medicine, enabling clinicians to generate region-specific clinical evidence for treatment applications.
Patient Protect launches to tackle discrimination against UK medical cannabis patients
UK medical cannabis patients face discrimination in housing, employment, law enforcement, and driving despite legal prescriptions, creating clinical care barriers that clinicians must understand to support patients effectively.
Study Links Rising Cannabis Use to Poor Mental Health – U.S. News & World Report
This article discusses research on cannabis use and mental health outcomes in older adults, relevant to clinicians treating this population where substance metabolism and cognitive effects require careful consideration.
Natural Approaches to Managing Chronic Inflammation – WorldHealth.net
One-Sentence Summary
This article explains how cannabinoids interact with the endocannabinoid system to modulate immune and inflammatory responses, which is clinically relevant for managing chronic inflammatory conditions.
Alabama medical cannabis program is now accepting patient registrations! – Blog
Alabama’s medical cannabis program now accepts patient registrations for qualifying conditions including chronic pain, PTSD, and anxiety, expanding clinical treatment options in a traditionally restrictive state.
House panel revives medical cannabis bill – Daily Tribune
The Philippines is establishing a regulated medical cannabis framework through House committee approval, creating potential treatment options and clinical practice standards in a previously restrictive jurisdiction.
More Kentucky children dying to ‘preventable’ overdoses, new report shows
Summary for Cannabis Clinician
This article documents increased pediatric cannabis poisonings in Kentucky, emphasizing that clinicians must counsel patients on secure storage to prevent accidental child ingestion of edibles and other cannabis products.
Legislation on medical cannabis: DOH bares conditions – Cebu Daily News
The Philippines’ Department of Health is establishing evidence-based regulatory conditions for medical cannabis legislation, directly impacting clinical access and prescribing protocols for healthcare providers.
Sober shift could reshape spending, but doctor warns THC may be the new vice – Fox Baltimore
This article examines the public health implications of declining alcohol use paired with rising cannabis/THC consumption, relevant to clinicians managing patient substance use patterns and substitution risks.
Secondhand marijuana smoke has fine particles that can cause asthma attacks and … – Instagram
Secondhand marijuana smoke contains fine particles that trigger respiratory inflammation and asthma exacerbation, relevant for clinicians counseling patients on inhalation exposure risks.
Nebraska’s Medical Cannabis Commission holds hearing on emergency regulations – KETV
Nebraska’s medical cannabis commission set a 90-day THC possession limit of 5 grams—potentially insufficient for therapeutic dosing in qualifying conditions, affecting patient treatment access.
Nebraska Bill Seeks To Shield Doctors Recommending Medical Cannabis From Arrest
Nebraska legislation would protect physicians recommending medical cannabis from criminal arrest, enabling doctors to practice evidence-based medicine without legal persecution.
The Week in Weed: February 27, 2026 – Lexology
Summary for Cannabis Clinician
Research on acute cannabis physiological and psychoactive effects provides clinicians with evidence-based data to better understand and counsel patients on immediate bodily responses to cannabis use.
First-of-its-kind long-term study at Virginia Tech shares how cannabis use can affect driving
This study examines how THC affects driving performance through metrics like reaction time and lane tracking, addressing clinicians’ need for evidence-based information on cannabis impairment assessment.
Expert breaks down hidden dangers of doctors prescribing medical marijuana – UNILAD
This article examines Cannabis Use Disorder prevalence rates among users and discusses concerns about medical marijuana prescription practices and their clinical implications.
Hemp article tells us why WI needs government regulations | Letter – Milwaukee Journal Sentinel
Hemp-derived cannabis products lack testing and labeling regulations that licensed dispensaries must follow, creating consumer safety risks that clinicians should understand when counseling patients.
Campaign Launched in Memory of Mum Who Helped Change UK Medical Cannabis Law
This article documents the medical case for cannabinoid treatment in pediatric drug-resistant epilepsy, where clinical evidence supports cannabidiol’s efficacy in reducing seizures.
New Cannabis Group Will Help Ground Policy In Science And Patient Experience As …
A new cannabis medicine group aims to align federal cannabinoid policy with scientific evidence and patient experiences during ongoing rescheduling discussions.
Hey Sonar: Rethinking your relationship with weed – CSU Signal
I can’t write this summary because the article content wasn’t provided—only the title and an empty summary field appear in your message. Please share the article text so I can create an accurate, clinically relevant one-sentence description.
‘Green lab’ helps Oregon officers recognize marijuana-impaired driving | The Astorian
Summary
Oregon law enforcement uses a “green lab” training program to identify impaired driving indicators, helping clinicians understand how impairment detection affects patient safety and legal outcomes.
Medical marijuana as someone working in healthcare industry : r/florida – Reddit
Cannabis Article Summary
This Reddit discussion covers healthcare workers’ experiences with medical marijuana in Florida, relevant to clinicians seeking peer perspectives on professional practice and patient care considerations.
Medical and recreational marijuana bills introduced in Kansas Legislature – KAKE
Kansas legislators are proposing medical and recreational cannabis legalization, which would expand clinical access for patients with qualifying conditions in a currently prohibition-only state.
Study highlights pros, cons of medical marijuana as its future in Tennessee remains unknown
Medical cannabis legislation in Tennessee faces uncertainty amid changing federal policy and state political positions, directly affecting clinical access and treatment options for practitioners.
The House Committee on Dangerous Drugs, together with the Committee on Health … – Facebook
The Philippines is developing medical cannabis legislation with regulatory frameworks and research provisions, relevant to clinicians seeking to understand emerging legal structures for therapeutic cannabis practice.
Health advocate underscores ‘real danger’ in medical cannabis legalization in PH
One-Sentence Summary
This article examines regulatory and healthcare capacity concerns raised by health advocates regarding medical cannabis legalization in the Philippines, relevant to clinicians implementing controlled therapeutic programs.
Extended moratorium on Oklahoma medical marijuana business licenses approved by House
Oklahoma’s House approved an extended moratorium on new medical marijuana licenses to address market oversaturation and associated regulatory and quality control issues affecting patient care.
MS Senate committee approves one medical marijuana bill, rejects another
Mississippi’s Senate committee is debating medical cannabis program requirements, specifically which patients qualify and how cannabis can be administered in clinical settings.
Major Canadian Study Reveals Significant Connection Between Cannabis Use, – Bioengineer.org
This article examines the bidirectional relationship between cannabis use and mood disorders, which is clinically relevant for assessing patient risk factors and treatment planning.
DOSE) (OTCQB: RDTCF) Advances QuickStrip™ Research Backed by NFL … – StreetInsider
Summary for Cannabis Clinician
Sublingual/buccal thin-film delivery bypasses hepatic metabolism, enabling faster onset and more consistent cannabinoid absorption compared to conventional oral formats.
420 with CNW – Texas Grapples with Increasing Cases of Marijuana DUI
Cannabis Clinician Summary
This article addresses cannabis-impaired driving safety and THC’s effects on driving ability, relevant to clinicians assessing patient safety and counseling cannabis users about impairment risks.
Recreational Marijuana – Cons | Britannica
Summary for Cannabis Clinician
This article examines the pharmacological interaction between cannabis and alcohol, including evidence that THC may reduce acute alcohol consumption—clinically relevant for treating patients with concurrent substance use.
Feds warn about medical cannabis & hemp in drug tests (Newsletter: March 6, 2026)
Federal agencies warn that drug tests cannot reliably distinguish medical cannabis use from legal hemp-CBD products, creating compliance challenges for clinicians treating patients.
Recreational Marijuana – Cons | Britannica
Summary
This article examines potential drawbacks of recreational marijuana legalization, providing clinicians with evidence-based information on documented harms relevant to patient counseling and clinical decision-making.
These Maine towns have the most cannabis businesses – The County
Summary
This article identifies Maine municipalities with the highest concentration of cannabis retail operations, relevant to clinicians for understanding local patient access patterns and dispensary availability.
DOH sets conditions on proposed medical cannabis legalization | Philippine News Agency
The Philippine DOH is establishing regulatory conditions for medical cannabis legalization, including compassionate access and research frameworks—critical for clinicians seeking legal prescribing pathways.
Building a global standard for cannabis vapes one terpene at a time – MJBizDaily
Summary for Cannabis Clinician
This article addresses efforts to establish standardized terpene profiles in cannabis vapes, which matters because terpenes may modulate cannabinoid effects and influence patient outcomes.
Cooney introduces bill to allow selling of low-potency cannabis beverages at liquor and wine stores
Cannabis Clinician Summary
Low-THC beverages have different absorption kinetics than inhalation, affecting onset time and dose predictability—clinically relevant for patient counseling on dosing expectations and individual variability.
How a virtual medical cannabis clinic is working on healthcare coverage for THC
This article examines how virtual cannabis clinics are addressing insurance coverage for THC treatments, highlighting the industry’s shift toward viewing medical cannabis as a cost-reducing healthcare intervention.
New Report: Poland Medical Cannabis Market Data Shows Full Post-Ban Recovery
Poland’s medical cannabis market recovered after an in-person consultation requirement disrupted telemedicine access, providing clinicians with data on regulatory impacts on patient care delivery.
DPH Commissioner goes ‘On the Record’ about measles outbreaks, cannabis – YouTube
Public health officials document rising THC potency in legal cannabis markets and associated risks for adolescent exposure, informing clinical assessment of patient use patterns.
The Coming Divide in Cannabis: Why the U.S. Market Remains Out of Reach for Global Operators
Summary for Cannabis Clinicians
This article examines how federal cannabis scheduling creates regulatory barriers preventing global companies from entering the U.S. market, affecting clinicians’ access to cannabinoid-based therapeutic options.
Brazil’s Cannabis Crossroads: New Rules, Old Truths, and the Road Ahead
Brazil’s updated cannabis framework formalizes medical cannabis integration into healthcare with regulated domestic cultivation, clarifying THC product oversight—essential knowledge for clinicians prescribing cannabinoid therapies.
Branford industrial site sold, to become cannabis growing operation – The Wilton Bulletin
Summary
An industrial property in Branford was sold and will be converted into a cannabis cultivation facility, representing commercial expansion of cannabis production operations.
Most cannabis users are ‘non-problematic’, Canadian data shows – leafie
Cannabis Use Patterns and Clinical Care
Canadian data demonstrates most cannabis users don’t exhibit problematic patterns, suggesting clinicians should assess individual risk rather than apply blanket assumptions about cannabis use.
US Cannabis Rescheduling: A Victory or a Federal Trap?
Federal rescheduling of cannabis to Schedule III affects regulatory oversight of medical programs but doesn’t resolve legal conflicts between state and federal law that clinicians must navigate.
Rapid Dose Therapeutics Advances Cannabinoid Studies for QuickStrip Drug Delivery Platform
Summary for Cannabis Clinicians
Rapid Dose Therapeutics is developing oral thin film technology to deliver cannabinoids with improved dosing accuracy and faster onset compared to traditional methods.
Scientists Reveal What Types Of Food The Marijuana ‘Munchies’ Make You Crave The Most
Cannabis increases appetite and shifts food preferences toward high-calorie, palatable foods rich in fats and sugars—knowledge that helps clinicians counsel patients on nutritional management and metabolic effects.
Key Congressional Committee Set To Vote On Delaying Federal Hemp THC Ban Next Week
Congressional committee will vote on delaying federal hemp-derived THC product restrictions, addressing regulatory gaps in product safety, labeling accuracy, and dosing standards affecting clinical practice.
Wisconsin Democrats File Bill to Legalize Adult-Use, Medical Cannabis; Regulate Intoxicating Hemp
Wisconsin Democrats proposed legislation to legalize adult-use cannabis, establish a medical program under state health oversight, and regulate intoxicating hemp products.
Rare Cannabinoid Company Expands Mood Collection with New THC-Free CBC Gummies …
Summary for Cannabis Clinician
This article covers CBC, a non-intoxicating cannabinoid with distinct endocannabinoid system mechanisms, relevant for clinicians evaluating alternative cannabinoid options for patients seeking mood support without intoxication.
Maryland Senate Delays Vote on Bill Allowing Firefighters to Use Medical Cannabis Off-Duty
This article covers Maryland legislation addressing off-duty medical cannabis use for firefighters with occupational health conditions, relevant to clinicians prescribing cannabis for PTSD, pain, and sleep disorders.
Upper Township unanimous for weed zone, overriding complaints from residents
Summary
Upper Township unanimously approved a cannabis retail zone despite resident opposition, establishing local regulatory framework that affects dispensary licensing and patient access.
Medical cannabis delivery app seeing growth in the DMV and Jamaica | DC News Now
Summary for Cannabis Clinician
This article covers medical cannabis delivery services in the DMV region and Jamaica, highlighting how improved access benefits patients with mobility or health limitations who cannot visit dispensaries.
Cannabis industry launches organization to further US policy changes with members from …
Cannabis Industry Coalition Formation
A cross-border cannabis industry organization is forming amid US federal rescheduling discussions, which directly impacts regulatory clarity for clinical cannabis providers and patient access.
The Best CBD for Seniors in 2026: Safe, Lab-Tested, and Easy to Use | stupidDOPE
This article reviews CBD products for seniors targeting chronic pain, sleep, anxiety, and inflammation—clinically relevant for practitioners advising older patients on non-intoxicating cannabinoid options.
Indiana lawmakers miss deadline, killing key cannabis bill | News | wthitv.com
Indiana’s failure to pass cannabis reform legislation leaves clinicians without updated state policy while neighboring states expand patient access, affecting clinical practice standards.
Hemp products had illegal THC amounts, mold, pesticides, and carcinogens, investigation finds
Unregulated hemp products frequently contain mislabeled THC levels and harmful contaminants, creating safety and compliance risks for clinicians advising patients on cannabinoid therapies.
Many NC candidates support medical marijuana legalization | Raleigh News & Observer
North Carolina candidates increasingly support medical marijuana legalization despite the state lacking legal patient access, indicating potential policy changes affecting clinical practice.
Does Weed Make You Harder or Easier to Manipulate? – Herb
Clinical Summary
Cannabis impairs cognitive functions critical to informed consent and decision-making; clinicians must assess THC dose effects on patients’ judgment capacity during treatment planning.
Aelis Farma’s AEF0117 THC Interaction Trial Withdrawn: What Investors Should Know
Summary for Cannabis Clinicians
Aelis Farma’s withdrawal of a CB1 inhibitor trial (AEF0117) impacts development of treatments targeting THC-related adverse effects and cannabis use disorder through selective receptor modulation.
Pres. Trump’s Marijuana Executive Mandate Accelerates MMJ International Holdings … – Newswire
Summary for Cannabis Clinician
This article discusses how federal executive actions on cannabis scheduling may create regulatory opportunities for pharmaceutical-grade cannabis manufacturers operating internationally, affecting clinical supply chains.
Veterans Groups Urge Congress To Expand Psychedelics And Marijuana Access To …
Summary for Cannabis Clinicians
Veterans groups advocate expanding VA access to cannabis and psychedelics to address high veteran suicide rates, reflecting evidence that current treatments are inadequate.
The Fire Station partners with Citizens for a Safe & Clean Lake Superior for cannabis vape …
Summary
The Fire Station partners with Citizens for a Safe & Clean Lake Superior regarding cannabis vape products, indicating collaboration between cannabis retailers and environmental/community safety organizations.
Boulder and CBD: The Entourage Effect Explained | About Boulder County Colorado
The Entourage Effect in Cannabis
**This article explains how multiple cannabis plant compounds work together to produce therapeutic effects that single isolated compounds cannot achieve alone.**
Indiana S.B. 250 could close Lafayette hemp-beverage sales without a key amendment
Summary for Cannabis Clinicians
Indiana S.B. 250 proposes restrictions on hemp-derived cannabinoid beverages, potentially limiting patient access to regulated products currently used for symptom management.
The Best CBD for Immune Support and Daily Resilience in 2026 | stupidDOPE | Est. 2008
This article examines CBD’s potential role in immune function and stress resilience by targeting the endocannabinoid system’s regulatory mechanisms—relevant to clinicians assessing cannabinoid applications for inflammation and homeostasis.
Louisiana Lawmakers Advance Adult-Use Cannabis Pilot Bill – KQKI News
Louisiana is advancing an adult-use cannabis pilot program, which provides clinicians data on legal market dynamics, consumption patterns, and regulatory outcomes relevant to patient care and clinical decision-making.
As Congress debates hemp-derived THC ban, Pa. lawmakers look for other options
Pennsylvania legislators are addressing regulatory gaps for hemp-derived THC products to clarify state oversight of intoxicating cannabis compounds currently unregulated since the 2018 Farm Bill.
West Virginia House approves bill allowing medical cannabis edibles | WV News
West Virginia legalized medical cannabis edibles, expanding patient access and providing alternative delivery methods for patients unable to use inhaled cannabis products.
The Wait is Over: Medical Cannabis set to roll out in April | WHNT.com
Alabama is launching a medical cannabis program in April for qualifying patients with chronic pain, PTSD, and anxiety, expanding treatment options in a traditionally restrictive state.
Branford industrial site sold, to become cannabis growing operation – New Haven Register
Summary
An industrial property in Branford was sold and will be converted into a cannabis cultivation facility, relevant to clinicians regarding local supply chain development and product availability.
Utah Lawmakers Pass Bill To Support Clinical Trials On Psychedelics For Veterans’ Mental Health
Summary
Utah lawmakers approved clinical trials of psychedelics for veterans’ mental health, expanding legal research opportunities relevant to cannabinoid clinicians treating similar conditions.
The Best CBD for Mental Clarity and Focus in 2026 | stupidDOPE | Est. 2008
This article reviews CBD’s mechanisms of action on multiple receptor systems and their potential effects on stress, mood, and cognition—relevant for clinicians evaluating CBD applications in mental health.
Study uncovers another reason not to skimp on sleep – ASU News
Sleep deprivation impairs prefrontal cortex function, increasing impulsive decision-making and substance use risk—clinicians should assess sleep patterns when evaluating cannabis use disorders.
OCM issues precautionary recall for select cannabis products tested by Keystone Lab – CBS 6 Albany
OCM Cannabis Product Recall
**Summary:** A New York regulatory body recalled cannabis products due to third-party lab testing integrity concerns, affecting product safety verification and clinician recommendations.
High Tide joins U.S. National Compassionate Care Council | HITI Stock News
High Tide joined the U.S. National Compassionate Care Council to advance evidence-informed medical cannabis access policies, helping clinicians navigate standardized regulatory frameworks for patient care.
Oklahoma Seeks to Backtrack on Medical Marijuana as Pitfalls Multiply
Oklahoma’s medical cannabis program faces regulatory challenges including oversaturation and inconsistent product oversight, prompting potential rollbacks that could impact patient access and clinical practice standards.
SA risks missing R40bn hemp industry opportunity without coherent strategy – Business Day
South Africa’s hemp industry lacks coordinated national strategy, risking R40 billion in potential revenue from CBD products and industrial applications relevant to clinical cannabis practitioners.
Kearney man charged with selling THC cartridges to undercover officer near school – Nebraska TV
Summary
A Kearney resident faces charges for selling THC cartridges to an undercover officer near a school, illustrating enforcement of cannabis sales restrictions in areas protecting minors.
The Office Is Issuing A Recall On Multiple Adult-Use Cannabis Products Tested By Keystone …
Cannabis Product Recalls Due to Testing Issues
This article covers regulatory product recalls in licensed cannabis markets when testing labs detect contaminants or labeling inaccuracies, which clinicians must track to ensure patient safety and regulatory compliance.
Linnea Achieves CEP Certification for Cannabidiol Isolate – Morningstar
Summary for Cannabis Clinicians
Linnea’s CEP certification confirms cannabidiol isolate meets strict European pharmaceutical standards for purity and consistency, enabling its use in regulated clinical and pharmaceutical applications.
Substance use on the rise among Gen Z in their early 20s – Medical Xpress
Summary
This article reports increasing substance use trends in Gen Z young adults, relevant to clinicians treating cannabis use patterns in this demographic.
Senate Bill would repeal 24% wholesale tax on marijuana – WTVB
Summary for Cannabis Clinician
A proposed Senate bill would eliminate a 24% wholesale tax on marijuana effective January 2026, which could affect cannabis product pricing and patient access to medical cannabis.
R40bn opportunity for hemp industrialisation in South Africa requires policy support – LSF study
Hemp industrialization in South Africa represents a R40 billion economic opportunity requiring policy support, relevant to clinicians as industrial scaling could improve medicinal cannabis product availability and affordability.
Bill to require stricter packaging requirements for marijuana edibles dies in Oregon legislature
A failed Oregon bill proposed individual wrapping and standardized dosing for cannabis edibles to prevent accidental ingestion and improve safety—regulatory standards clinicians may need to address with patients.
Germany’s Medical Cannabis Boom: Data-Driven Insights for Investors | INN
Germany’s medical cannabis market growth is analyzed through patient data demonstrating therapeutic effectiveness, providing clinicians evidence-based insights for treatment protocols and outcomes.
New study reveals how many Americans use CBD — and why | GreenState
This study provides epidemiological data on CBD usage patterns and demographics across the U.S. population, offering clinicians evidence-based information on patient prevalence and reported therapeutic applications.
New Report: Poland Medical Cannabis Market Data Shows Full Post-Ban Recovery
Poland’s medical cannabis market recovery post-ban indicates expanding European regulatory acceptance and renewed patient access, informing clinicians of emerging treatment availability in the region.
Wisconsin Democrats Introduce Cannabis Legalization Bill – Law360 Tax Authority
Wisconsin Democrats introduced legislation to legalize recreational cannabis with regulatory and tax frameworks, affecting clinical practice standards and patient access in the state.
CBD oil restores quality of life for sisters, sharing concerns about new regulations with hemp …
Two sisters report quality-of-life improvements with THCA-containing hemp products while advocating against regulations that could limit access to these compounds.
ACLU previews cannabis & guns arguments for Supreme Court (Newsletter: February 26, 2026)
One-Sentence Summary
Federal cannabis prohibition may legally restrict gun ownership for state-legal users, creating clinical documentation and patient counseling implications for cannabis clinicians.
Texas Voters Disapprove Of How State Officials Are Handling Marijuana And THC Laws, Poll Shows
Texas voters disapprove of state marijuana and THC law management, signaling potential political pressure for regulatory reform that could affect clinical cannabis access and patient care standards.
Bridging the Gap: Medical Cannabis, Regulators, and the Reality of Clinical Accountability
Cannabis Clinician Summary
This article examines how medical cannabis providers lack standardized accountability measures for patient outcomes, creating challenges between clinical practice demands and existing regulatory frameworks.
March 5 webinar offers parents lessons on drug/alcohol trends – Rice County, MN
Rice County parents can learn about current youth cannabis trends and health impacts through an evidence-based educational webinar, supporting informed conversations with adolescents.
Michigan’s Marijuana Tax Experiment Should Be An Urgent Warning To Other States (Op-Ed)
Michigan’s high cannabis taxes are driving consumers to illicit markets, reducing legal sales and demonstrating how tax policy directly impacts the viability of regulated cannabis operations.
Curaleaf Earnings: International Growth Offsets Domestic Decline from Continued Price Compression
Curaleaf’s earnings show international growth cannot offset domestic US cannabis market decline from illegal competition and pricing pressure—critical for clinicians assessing legal dispensary viability and product availability.
Kentucky bill would expand cannabis drink sales beyond liquor stores – WKYT
Cannabis Clinician Summary
Kentucky’s SB 223 would expand cannabis beverage distribution channels beyond liquor stores, requiring clinicians to understand broader patient access patterns and consumption settings.
Advanced drug testing improves patient care at MUSC
MUSC’s advanced drug testing detects THC exposure more accurately and affordably, enabling clinicians to better assess patient cannabis use and individualize treatment decisions.
As lawmakers in Richmond continue debating a path forward for retail marijuana sales …
Virginia legislators are developing retail marijuana regulations despite insufficient state-specific research on health and social impacts, creating evidence gaps clinicians need for clinical guidance.
Europe’s Medical Cannabis Market Surges Toward $13 Billion: Last Week in Weed Feb. 23 …
Europe’s medical cannabis market expansion toward $13 billion reflects growing regulatory approval and commercial availability, directly impacting clinician access to diverse cannabis products for patient treatment options.
Facing Hemp Ban, PA Lawmakers Race to Regulate THC Drinks and Products
Pennsylvania is establishing state regulations for THC beverages and hemp products amid federal enforcement, creating important regulatory clarity for clinicians treating patients using these increasingly available products.
Ricketts addresses Congress leaving Nebraska off list protecting state medical cannabis laws
Summary for Cannabis Clinicians
This covers a U.S. Senator’s unclear position on federal protections for state medical cannabis laws, which directly affects the legal framework within which clinicians operate.
The Wait is Over: Medical Cannabis set to roll out in April | WKRG.com
Alabama’s medical cannabis program launching in April 2024 provides clinicians with legal dispensary access to regulated cannabis products for patient treatment recommendations.
From Billion-Dollar Hemp Drinks to FDA Cease-and-Desist Letters: The Cannabis Industry’s …
Summary for Cannabis Clinicians
The FDA is enforcing regulations against cannabis beverage companies making unsubstantiated health claims, which clinicians should track to understand evolving regulatory standards affecting patient product information.
Popular Diabetes Drugs May Help Combat Multiple Addictions, Major Study Shows
Summary
This article discusses how diabetes medications may treat multiple addictions, which is relevant to cannabis clinicians managing patients with concurrent substance use disorders.
Also Noted
Bridgeport Police Make Arrests, Seize 50 Pounds Of THC Products At Local Smoke Shops
Cannabis Clinician Summary
Law enforcement seized THC products from retail locations during compliance inspections, highlighting regulatory enforcement gaps that may affect product safety standards and legal market access for patients.
RYTHM (RYM) 2025 results: THC licensing growth but continued heavy losses – Stock Titan
RYTHM reported expanding hemp-derived THC product licensing despite ongoing financial losses, relevant to clinicians tracking market trends and product availability in cannabis therapeutics.
Massachusetts Ballot Measure To Roll Back Marijuana Legalization Is Opposed By Most …
Summary for Cannabis Clinician
A Massachusetts survey shows majority opposition to rolling back marijuana legalization, which matters for understanding patient access sustainability and regulatory stability in clinical practice.
Massachusetts Poll: 63% Oppose Repealing Marijuana Legalization, Only 20% in Support – Reddit
Cannabis Clinician Summary
A Massachusetts poll shows 63% public opposition to repealing marijuana legalization, indicating strong voter support for legal access that affects clinical practice and patient treatment options.
N.S. RCMP crack down on cannabis dispensaries – YouTube
Nova Scotia RCMP enforcement action against cannabis dispensaries may impact patient access to cannabis products and clinician-patient treatment plans in the region.
Retail cannabis market nearly finalized in the Commonwealth – WCYB
Cannabis Clinician Summary
Virginia is establishing a legal adult-use retail cannabis market, which may increase patient access to regulated products and create clinical documentation opportunities for practitioners.
Marijuana tax payouts dip in Michigan amid sales slump
Cannabis Article Summary
This article covers declining marijuana tax revenue in Michigan and its impact on local government funding for public services, which affects cannabis clinicians through potential changes in healthcare infrastructure and regulation support.
Medical cannabis delivery app seeing growth in the DMV and Jamaica | DC News Now
This article covers a medical cannabis delivery app expanding in the DC/Maryland/Virginia region and Jamaica, relevant to clinicians interested in cannabis distribution innovations and patient access models.
Clarence Thomas Calls Out Attorney For Relying On ‘Illegality’ Of Marijuana In Gun Purchase Case
Cannabis-Related Legal Matter for Clinicians
Justice Thomas questioned legal arguments based on marijuana’s federal illegality in a gun rights case, with potential implications for cannabis policy and clinical practice.
‘Sober curious’ Gen Z adults drinking more than millennials were at same age, study finds
This article reports increased cannabis trial rates among Gen Z adults compared to their younger selves, relevant to clinicians assessing population trends and patient demographics.
High Schools Are Losing the Struggle to Block Pot—Even During Class – WSJ
Cannabis Article Summary
This article documents increased marijuana use among high school students following legalization, highlighting a public health concern for clinicians treating adolescent cannabis-related issues.
Mellow Fellow: Scientifically Powered Cannabinoids – Cannabis Now
Mellow Fellow is a hemp-derived cannabinoid company founded by a pharmacist, relevant to clinicians for understanding diversified cannabinoid product formulations beyond single-compound approaches.
Cash, not rescheduling, is driving cannabis lending decisions – MJBizDaily
Cannabis lenders prioritize borrower cash flow over federal rescheduling status, which affects clinic financing availability and operational costs for medical cannabis practitioners.
Missouri Auditor Recommends Marijuana Tax Revenue Policy Change – Missourinet
Missouri offers unusually large tax discounts to marijuana retailers, prompting state auditor recommendations for policy revision—relevant for understanding cannabis product pricing and patient access costs.
Did you know this was happening in Oklahoma? – Instagram
Summary for Cannabis Clinician
Law enforcement in Oklahoma has dismantled thousands of illegal Chinese-operated marijuana cultivation operations, which impacts the legal cannabis market and public health oversight.
Cannabis Stocks To Add to Your Watchlist – March 6th – Defense World
This article reviews cannabis company stocks and business operations, relevant to clinicians monitoring the commercial cannabis industry’s development and its potential impact on medical cannabis availability and research.
3 children rushed to hospital after teacher ‘gave them weed gummies to celebrate birthday …
Cannabis Clinician Summary
A teacher allegedly distributed THC-containing edibles to elementary school children, resulting in hospitalizations—highlighting accidental pediatric cannabis exposure risks and product safety concerns.
Drug Arrests Surge 1,000, Driven by New Synthetic Narcotics
Cannabis Clinician Summary
This article documents increased drug arrests involving synthetic cannabis alongside other psychotropic substances, relevant to clinicians treating patients exposed to unregulated synthetic cannabinoid products.
New study reveals surprising benefit of GLP-1s that has nothing to do with weight loss
GLP-1 receptor agonists may reduce addiction to cannabis and other substances, offering clinicians a potential new therapeutic tool beyond weight management for patients with concurrent substance use disorders.
3 Children Rushed to Hospital After Teacher Allegedly Gave Them Weed Gummies
This article covers a case involving alleged unauthorized THC product administration to minors in an educational setting, highlighting legal and clinical risks of cannabis product safety and child protection.
A Promising Approach: Why young Indians are increasingly leaning into holistic wellness practices
Summary for Cannabis Clinician
This article discusses CBD and cannabinoid interest among young Indians pursuing holistic wellness, indicating emerging market demand and patient demographic shifts relevant to clinical practice.
Baxter County man facing 10 felony charges after 5 children test positive for THC | KTLO
Summary for Cannabis Clinician
A Baxter County man faces 10 felonies after five children tested positive for THC, highlighting child safety concerns and unintended pediatric cannabis exposure risks.
The hardest job in cannabis, and the most lucrative, is in cultivation – MJBizDaily
Summary for Cannabis Clinician
Understanding cultivation’s economic importance helps clinicians contextualize cannabis product quality, supply chain reliability, and the professional standards affecting patient access to medicine.
Growing Pains – richmondmagazine.com
Cannabis Business Profitability Disparities
This article examines profitability rates among cannabis businesses, revealing that only 27% are profitable with significant racial disparities—information relevant to clinicians understanding industry sustainability and access issues.
2 local breweries part of lawsuit to keep THC drinks on store shelves
Cannabis Article Summary
Local breweries are suing to maintain legal sales of hemp-derived THC beverages in Ohio as regulatory restrictions threaten product availability.
GOP Congressman Running For Florida Governor Admits To Selling Marijuana Despite …
A Florida GOP gubernatorial candidate’s past marijuana sales and voting record on cannabis banking and research legislation may influence state cannabis policy and clinical access.
Judge’s ruling could force transparency in Menominee marijuana mess – MLive.com
A court ruling may require disclosure of funding sources behind a Menominee ballot initiative restricting marijuana retailers, affecting cannabis business operations and regulatory transparency.
Does marijuana help relieve or worsen your pain associated with fibromyalgia? – Reddit
This article discusses patient experiences with cannabis use for fibromyalgia pain management, providing real-world evidence relevant to clinicians evaluating cannabis efficacy for chronic pain conditions.
2 Cincinnati breweries sue State of Ohio over looming THC drink ban – WCPO
One-Sentence Summary
Ohio breweries are challenging a state ban on THC-containing beverages effective March 2026, affecting clinician counseling on legal cannabis product availability and patient access.
Proof Launches California’s First 100% Legal Cannabis Pet Product
Cannabis Pet Product Article Summary
This article covers the launch of a pharmaceutical-grade cannabis product for pets in California, relevant to clinicians interested in expanding endocannabinoid system applications beyond human medicine.
Rare Cannabinoid Company Debuts CBC Mood Gummies – Prepared Foods
A cannabinoid company launched CBC-infused gummies for mood support, expanding product offerings in response to increased clinical and consumer interest in minor cannabinoids beyond THC and CBD.
Your marijuana smoke in my nose? Arizona lawmakers say ‘no’
Arizona lawmakers enacted secondhand marijuana smoke restrictions, establishing legal boundaries between personal cannabis use and neighbors’ exposure—relevant for clinicians counseling patients on compliance and public health implications.
Competitiveness fears weave through budget hearings – CommonWealth Beacon
Cannabis Article Summary
Massachusetts budget hearings addressed cannabis research funding alongside economic development priorities, relevant to clinicians tracking regulatory and research landscape changes.
The Best CBD for Joint Pain and Mobility in 2026 | stupidDOPE | Est. 2008
This article reviews CBD products for joint pain management, relevant to clinicians counseling patients on cannabinoid options for inflammation and mobility concerns.
Marijuana prices have been taking a nosedive. What comes next? – The Boston Globe
Summary for Cannabis Clinician
Market oversaturation is driving marijuana price declines, which may affect patient access, dispensary viability, and the sustainability of regulated cannabis supply chains.
EO Care Appoints William Fleming and Kristi Savacool to Board of Directors, Reinforcing Its …
EO Care expanded its board of directors with two new appointments, strengthening governance and oversight of its cannabinoid-based clinical treatment offerings.
Two Dakota nations sign cannabis compacts with state of Minnesota | MPR News
Minnesota Governor Tim Walz signed cannabis compacts with two tribal nations, establishing regulatory frameworks that affect cannabis access and compliance requirements for clinicians serving these communities.
SC Republican Party State Chairman says ‘no’ to THC-infused drinks and other products
Summary for Cannabis Clinician
South Carolina’s Republican Party leadership opposes THC-infused beverages while the state maintains legal status for CBD oil and THC-A hemp, relevant to clinicians navigating state regulatory frameworks.
Falling marijuana revenue and the fight over Michigan’s new cannabis tax
Michigan lawmakers are debating repealing a 24% wholesale cannabis tax amid declining revenue, which affects product costs and patient access to medical cannabis.
D.C. proposes prorated cannabis licensing fees – Outlaw Report
D.C. is proposing reduced first-year licensing fees for new medical cannabis facilities, lowering startup costs for operators serving patients.
Virginia delays cannabis business registration | | mesabitribune.com
Virginia Cannabis Zoning Regulations
Virginia enforces a 1,000-foot distance requirement between cannabis businesses and schools, affecting where clinicians can legally operate dispensaries or clinics.
Optimizing Post-Harvest Cannabis Processing for Sustained Efficiency, Quality, and Yield
This article covers post-harvest optimization techniques including automation, facility design, and climate control—relevant to clinicians for understanding how processing methods affect cannabis product quality and consistency.
Cincinnati breweries file lawsuit over Ohio’s ban on intoxicating hemp – YouTube
Cincinnati breweries are challenging Ohio’s prohibition on intoxicating hemp products, raising legal questions about cannabis regulation that may affect clinical cannabinoid product availability and patient access.
Arrests, Arraignments for Monday, March 2 – County 17
Cannabis Clinician Summary
This article documents criminal arrests for cannabis possession violations, including THC concentrates and impaired driving charges, relevant for clinicians assessing patient legal exposure and substance use patterns.
Meet Pips: Grön’s Crispy, Crunchy, Cannabis-Infused Chocolate Pieces Arrive in New York
Summary for Cannabis Clinician
This article covers the launch of a microdose-friendly cannabis edible product (5 mg THC per piece) with variable cannabinoid ratios, relevant to clinicians counseling patients on precise THC dosing and product options.
Commission questions fairness of security requirements at a Costa Mesa cannabis dispensary
A Costa Mesa cannabis dispensary seeks to relax security regulations, which matters to clinicians as compliance standards affect patient access and operational legitimacy.
Owner of Wichita dispensary indicted for trafficking marijuana from his stores – KWCH
Cannabis Clinician Summary
A dispensary owner faced federal charges for marijuana distribution and firearm possession, illustrating regulatory enforcement risks clinicians should understand when referring patients to licensed retailers.
Supreme Court questions denying gun rights to marijuana users in test of the 2nd Amendment
The Supreme Court examined whether marijuana use alone justifies firearm restrictions, a decision affecting legal cannabis patients’ constitutional rights and clinician liability considerations.
Kinston police execute 34 search warrants in marijuana, THC investigation – WCTI
Summary for Cannabis Clinician
Kinston Police concluded a three-month investigation into illegal marijuana and THC distribution, executing 34 search warrants to address unregulated product markets affecting patient safety and legal compliance.
Forsyth Co. drug task force seizes over $1 million of THC vape pens | wfmynews2.com
Summary for Cannabis Clinician
A Forsyth County drug task force seized over $1 million in THC vape pens from an 18-year-old, highlighting illegal cannabis product distribution and enforcement activity relevant to clinical understanding of market dynamics.
Marijuana Can Help With These Tips To Get A Spring Body – The Fresh Toast
This article discusses cannabis compounds’ interaction with the endocannabinoid system for pain regulation, relevant to clinicians evaluating therapeutic applications and patient outcomes.
Trulieve Cannabis slashes 58 jobs at Florida call center – MJBizDaily
Trulieve, Florida’s largest cannabis retailer, cut 58 jobs at its call center following earnings reports and regulatory challenges, affecting patient access to customer service.
Giant Craft Brewer Falls to a Cannabis Conglomerate in a Fire Sale—Nearly 500 Jobs Disappear
Key Takeaway
Tilray’s acquisition of BrewDog’s brewing operations marks cannabis industry consolidation into beverage production, relevant for clinicians monitoring cannabis product diversification and market expansion trends.
Connecticut Lawmakers Approve Bill To Expand Psychedelics Pilot Program In Anticipation …
Connecticut lawmakers approved legislation expanding a psychedelics pilot program, enabling clinical research into psychedelic-assisted therapies alongside cannabis, potentially informing future treatment protocols.
Police say package with meth and THC wax recovered inside Newberry Correctional Facility yard
Summary for Cannabis Clinician
A correctional facility drug seizure involving THC wax illustrates supply chain security challenges and incarcerated population substance access issues relevant to clinical cannabis programs.
3 arrested following an attempt to smuggle drugs into Newberry Correctional Facility – WLUC
Cannabis Clinician Summary
Three individuals were arrested after attempting to smuggle THC and methamphetamine into a correctional facility, highlighting supply chain security concerns in institutional settings.
Tilray Brands, Inc. (TLRY) Strengthens U.S. Footprint With Long-Term Carlsberg Partnership
Tilray’s partnership with Carlsberg expands its U.S. distribution capabilities and market presence, potentially improving patient access to cannabis-derived medical products through established beverage distribution networks.
Police raid Monett home near school, seize marijuana products, mushrooms and firearms
A police raid in Monett, Missouri recovered marijuana products and firearms from a residential location near a school, resulting in drug and weapon charges relevant to product safety and legal compliance concerns.
NEW INFO: 26 vape shops, 8 homes raided in Kinston police crackdown – WITN
Summary for Cannabis Clinician
Kinston police conducted raids on vape shops and residences investigating illegal marijuana and THC product sales, relevant to clinicians assessing patient access to unregulated cannabis sources.
Cannabis, beer, and wellness: Meet Tilray Brands, Ireland’s newest publican – The Currency
Summary for Cannabis Clinician
Tilray Brands acquired an Irish pub operator for £33m, expanding their cannabis, beer, and wellness portfolio into new markets, demonstrating cannabis industry diversification beyond traditional medical channels.
More than 500 pounds of marijuana seized by Arkansas State Police in Crawford County
Arkansas State Police seized 500 pounds of marijuana during a traffic stop, resulting in felony trafficking charges—relevant to clinicians monitoring legal/regulatory enforcement affecting patient access and supply chain integrity.
Man accused of running illegal marijuana operation gets $100K bond after AG misses hearing
A defendant accused of operating a major illegal cannabis operation received a reduced bond after prosecutors missed a court hearing, highlighting enforcement challenges in the illicit market.
Man arrested in Lenoir County with marijuana and pills found – WNCT
Cannabis Clinician Summary
A law enforcement arrest involving cannabis possession with intent to distribute and Schedule II controlled substances illustrates regulatory enforcement mechanisms relevant to clinical cannabis programs.
THC Therapeutics, Inc. Announces Filing of 10-K and Provides Corporate Update
THC Therapeutics Files Annual Report
THC Therapeutics, Inc. disclosed its 10-K annual filing and corporate updates, providing clinicians with regulatory compliance documentation and financial performance data relevant to the company’s cannabis operations.
Trulieve’s 2025 Loss Narrows On Flat Sales Might Change The Case For Investing In …
Trulieve’s Financial Performance Summary
This article examines Trulieve’s 2025 financial results showing reduced losses despite flat sales, relevant to clinicians assessing cannabis industry stability and product availability for patients.
In Upper, not all public comment is against cannabis sales – Ocean City Sentinel
Township Committee debates cannabis retail licensing with mixed public opinion on a proposed Roosevelt Boulevard shop location.
Upper Township OKs cannabis sales despite public opposition – Ocean City Sentinel
Upper Township approved retail cannabis sales despite community opposition, establishing a commercial dispensary location relevant to clinicians monitoring patient access and local market availability.
Pioneer Valley Trading Co. requests opportunity to grow marijuana in Southwick
Cannabis Article Summary
A Massachusetts marijuana business seeks cultivation licensing in Southwick, relevant to clinicians monitoring regulatory expansion and local supply chain development affecting patient access.
Racine home drug bust; children test positive for drugs, 2 charged – FOX6 News Milwaukee
Cannabis Clinician Summary
A Racine drug bust recovered THC products from a home where children tested positive for drugs, highlighting pediatric cannabis exposure risks and contamination concerns.
Craft beer business struggling with rise of THC alternatives – YouTube
Summary for Cannabis Clinician
Craft beer industry declining as THC products gain market share, indicating shifting consumer preferences toward cannabis alternatives for recreational purposes.
Craft beer business struggling with rise of THC alternatives | wfmynews2.com
Summary for Cannabis Clinician
The craft beer industry reports 5% production decline, potentially reflecting consumer preference shifts toward cannabis and THC products as alternative intoxicants.
ASX Cannabis Stocks in 2026: Is the risk worth the reward?
Summary
This article examines ASX-listed cannabis companies’ risk-reward profiles in 2026, featuring Cann Group as an early Australian industry participant with research licensing.
Accused $1.5B illegal marijuana operation ringleader freed from OK County jail on $100K bond
Summary for Cannabis Clinician
This article covers the release of an accused operator of a large-scale illegal marijuana operation in Oklahoma, relevant to understanding illicit market competition and regulatory enforcement gaps affecting licensed cannabis providers.
Marijuana tax payouts dip in Michigan amid sales slump | WANE 15
Cannabis Tax Revenue Decline in Michigan
Michigan’s marijuana tax revenues are decreasing due to reduced sales, affecting state funding allocations that clinicians should monitor for impacts on cannabis research, medical programs, and regulatory resources.
Cannabis Europa London 2026 Debuts New VIP Experience
Cannabis Europa London 2026 features the Business of Cannabis Awards returning to London, covering industry recognition relevant to cannabis professionals and clinical practitioners.
Thumbs Up/Thumbs Down: March 6, 2026 | News, weather and sports from Alexandria, Minnesota
Summary
Alexandria, Minnesota prohibits cannabis/THC use in municipal parks and public spaces, establishing local regulatory boundaries that clinicians should understand when counseling patients about legal consumption locations.
12 Best Alcohol Stocks to Buy Right Now – Insider Monkey
This article lists top alcohol stocks but includes Tilray Brands, a cannabis company involved in medical cannabis research and cultivation relevant to clinical practice.
These Maine towns have the most cannabis businesses – Bangor Daily News
This article identifies Maine towns with the highest concentration of licensed cannabis cultivators, manufacturers, and retailers, relevant for clinicians tracking product availability and local market distribution patterns.
Supreme Court Skeptical of Marijuana User Gun Ban in Oral Arguments – Reddit
Cannabis and Firearm Access
This covers Supreme Court oral arguments on whether federal law can ban gun ownership for marijuana users, relevant to clinicians documenting patient substance use and understanding legal implications.
Yunlin prosecutors indict Vietnamese nationals for marijuana smuggling – Focus Taiwan
Vietnamese nationals were indicted for smuggling marijuana from Thailand into Taiwan, highlighting international drug trafficking enforcement relevant to clinicians understanding cannabis’s illicit supply chains and legal consequences.
Piffton’s bold flavors shine atop a sometimes boring THC market – For The Win
Summary for Cannabis Clinician
Piffton product differentiates through prominent terpene profiles and floral flavor characteristics in the THC market, relevant to understanding consumer preferences and product variability in cannabinoid formulations.
Organigram Acquires Sanity Group: When Big Tobacco Moves into Cannabis
Cannabis Clinician Summary
This article covers a tobacco company’s acquisition of a cannabis producer, raising questions about industry consolidation’s impact on cannabis research and clinical practice.
Iowa man charged after DeKalb Co. traffic stop reveals over 9 pounds of cannabis – WIFR
A traffic stop in DeKalb County resulted in the arrest of an Iowa man carrying over 9 pounds of cannabis, illustrating law enforcement’s ongoing enforcement of cannabis possession limits.
Utah Lawmakers Pass Bill To Support Clinical Trials On Psychedelics For Veterans’ Mental Health
Cannabis Clinician Summary
Utah lawmakers advanced legislation enabling clinical trials of psychedelics for veteran mental health, expanding research opportunities beyond cannabis for treatment-resistant conditions.
ACCUSED MARIJUANA RINGLEADER RELEASED ON BOND The alleged leader of a $1.5 …
Summary for Cannabis Clinician
A major illegal marijuana operation leader was released on bail pending trial, relevant to understanding the illicit market’s scale and enforcement landscape affecting legal cannabis practice.
Medical marijuana as someone working in healthcare industry : r/florida – Reddit
Healthcare workers’ hesitancy to disclose medical marijuana use to physicians due to employment concerns, which impacts clinical documentation and patient safety assessment.
Suns forward Dillon Brooks arrested on suspicion of DUI – The New York Times
This article covers a DUI arrest involving cannabis and highlights that Arizona law permits impaired driving charges for marijuana use, which is relevant to understanding cannabis-related impairment assessment and legal implications.
Where Americans Spend their Trillions on Goods and How that Changed since 2015
Summary for Cannabis Clinician
This article examines U.S. consumer spending patterns on goods since 2015, noting cannabis retail sales increased 3.6% year-over-year, providing market data relevant to understanding patient access and commercial availability trends.
17-year-old charged with DUI after crashing into Knoxville home, leaving the scene, police say
This case documents a minor operating a vehicle under the influence of cannabis and alcohol, relevant to clinicians assessing impairment risks and counseling adolescent patients on substance use and driving safety.
Three arrested after Holton search warrant – MSC News
Summary for Cannabis Clinician
Law enforcement arrested individuals during a Holton search warrant operation involving THC possession and felony drug violations, illustrating regulatory enforcement relevant to clinical practice settings.
Tilray Brands, Inc. (TLRY) Acquires BrewDog – Insider Monkey
Cannabis Clinician Summary
Tilray Brands’ acquisition of BrewDog expands a major cannabis producer’s portfolio into beverage markets, potentially increasing cannabis product diversity available for clinical consideration.
Substitute teacher accused of giving children cannabis gummies to ‘celebrate’ birthday – Cincinnati
A substitute teacher allegedly distributed cannabis edibles to students, raising critical concerns about product safety, child access prevention, and liability in cannabis-regulated markets.
Marijuana card : r/AskLE – Reddit
One Sentence Summary
Cannabis use history can disqualify applicants from firearm permits under federal law, which clinicians should document when evaluating patients for medical cannabis.
Excelsior Springs tables marijuana drive-thru vote, honors outgoing city manager
A city council postponed zoning approval for marijuana dispensary drive-thrus following youth prevention advocacy concerns, directly affecting cannabis retail access and public health policy.
Inside Apotheca Cannabis Dispensary in Gastonia, NC – Gaston Gazette
This article features Apotheca Cannabis Dispensary in Gastonia, NC, highlighting available edible products through a staff demonstration, relevant to clinicians tracking dispensary operations and product offerings in their region.
Primghar man arrested for OWI, marijuana | News – nwestiowa.com
Cannabis Clinician Summary
A man was arrested for operating while intoxicated with cannabis present in his vehicle, illustrating impaired driving enforcement and potential legal consequences relevant to cannabis use counseling.
medical marijuana and pregnancy : r/eds – Reddit
This post addresses maternal cannabis use during pregnancy, a clinical concern requiring evidence-based counseling on risks and benefits for pregnant patients with EDS.
From startup seedling to cannabis powerhouse, Verano has navigated the industry’s ups and downs
This article covers Verano’s growth in the cannabis industry amid widespread state-level cultivation oversupply, relevant to clinicians assessing product availability and pricing pressures affecting patient access.
Teen who killed 6 in THC crash got 65 years. Can Trump help him? – USA Today
Cannabis Clinician Summary
A teenager received a 65-year sentence for a fatal crash involving THC impairment, illustrating legal and clinical implications of cannabis use while driving and potential criminal justice outcomes.
LA’s $400 Million Cannabis Tax Gap: Last Week in Weed March 2–9, 2026
Cannabis Tax Gap in Los Angeles
This article examines Los Angeles’s $400 million cannabis tax revenue shortfall, relevant to clinicians for understanding regulatory and business challenges affecting cannabis industry operations and patient access.
Forest Lake mayor to open city’s first cannabis dispensary | kare11.com
Summary for Cannabis Clinician
The mayor of Forest Lake is opening the city’s first legal cannabis dispensary, expanding patient access to regulated cannabis products in the region.
New medical Marijuana pick-up facility opening in Tyler – YouTube
A medical marijuana dispensary is opening in Tyler, Texas, expanding patient access to cannabis in East Texas and providing clinicians with a local resource for patient medication fulfillment.
Forest Lake mayor to open city’s first cannabis dispensary – YouTube
Summary for Cannabis Clinician
A Forest Lake mayor is opening the city’s first licensed cannabis dispensary, expanding local patient access to regulated cannabis products.
The arrest of Phoenix Suns star Dillon Brooks in Scottsdale Friday has drawn new attention …
Summary for Cannabis Clinician
This article covers Arizona’s DUI laws regarding cannabis impairment following an NBA player’s arrest, highlighting clinical and legal implications of marijuana intoxication assessment standards.
Beleaf cannabis dispensary opens in Medford after yearlong delay – Newsday
Beleaf cannabis dispensary opened in Medford after regulatory delays, reflecting Long Island’s expanding legal cannabis market and the approval challenges affecting dispensary availability.
Citing ‘irreparable harm,’ TD Garden owner sues ‘The Boston Garden’ dispensary
Cannabis Article Summary
A trademark dispute between a cannabis dispensary and TD Garden’s owner highlights legal risks clinicians should understand when recommending products from establishments operating under contested brand names.
WSU students earn national honors at biomedical research conference
Cannabis Clinician Relevance
This article covers undergraduate biomedical research recognition and does not address cannabis-related topics or clinical applications relevant to cannabis medicine.
This Midwest state could be the next to legalize psilocybin – GreenState
This article covers Illinois potentially legalizing psilocybin, demonstrating how cannabis-progressive states are expanding psychedelic research and regulation, relevant to clinicians tracking evolving therapeutic substance policies.
Eastview Mall cannabis dispensary approved in Victor – Democrat and Chronicle
Summary for Cannabis Clinician
A cannabis dispensary received approval to operate within a major shopping mall, expanding retail access and potentially increasing patient convenience for obtaining cannabis products.
Three charged for reported marijuana at playground | News | ncnewsonline.com
Three individuals were charged after police seized over half a pound of suspected marijuana from a vehicle at a playground, highlighting law enforcement activity relevant to cannabis regulation and public health contexts.
Zero Tolerance bust closes four dispensaries in Rosamond – Edwards AFB – Air Force
Cannabis Clinician Summary
Law enforcement closed four Rosamond dispensaries near Edwards AFB, seizing 330+ pounds of processed marijuana in a “Zero Tolerance” operation targeting illegal sales and conspiracy.
4 arrested after Louisville police seize 3D-printed guns, THC vapes | Crime Reports – WDRB
Cannabis Clinician Summary
Police arrested four individuals possessing 120 THC vape pens alongside illegally manufactured firearms, highlighting the overlap between cannabis distribution networks and weapons trafficking that clinicians should recognize when assessing patient safety risks.
The Best CBD Oil in the United States in 2026 | stupidDOPE | Est. 2008
This article reviews CBD oil products available in the United States, focusing on formulations with minimal additives for clean cannabinoid delivery and endocannabinoid system interaction—relevant for clinicians evaluating patient treatment options.
See how much people are spending on marijuana in Michigan and where at – mlive.com
Michigan’s recreational marijuana market reached $3.17 billion in sales last year, providing clinicians with data on patient consumption patterns and market trends relevant to clinical practice.
The ITA reports that Ju-Jitsu athlete Ilyas Aasli has been sanctioned with a two-year period …
One Sentence Summary
Cannabis clinicians should note this ITA sanction case demonstrates how THC appears on prohibited substance lists, affecting athlete eligibility and anti-doping compliance monitoring.
More than 1.36 million pounds of marijuana flower was purchased in Michigan last year.
Cannabis Clinician Summary
Michigan’s 1.36 million pounds of annual cannabis flower sales data demonstrates the substantial market volume and tax revenue generation from legal cannabis commerce relevant to clinical practice patterns and patient access.
The Future of Legal Magic Mushrooms is Complicated – Cannabis & Tech Today
This article discusses CBD’s immune system interactions and cannabis research related to COVID-19, relevant to clinicians considering immunomodulatory effects in patient treatment protocols.
Friend used me as a source of Marijuana for his clearance investigation – Reddit
Summary for Cannabis Clinicians
This covers a disclosure dilemma where a security clearance applicant’s marijuana use became known to their professional reference, raising concerns about documentation accuracy and interpersonal trust in substance use reporting.
LaGrange police arrest suspected drug trafficker, find dozens of pounds of marijuana
Cannabis Clinician Summary
Law enforcement arrested a suspected marijuana trafficker with firearm charges, illustrating the legal consequences of unlicensed cannabis distribution and the intersection of drug trafficking with weapons offenses.
Ongoing marijuana odor issue : r/Apartmentliving – Reddit
Summary for Cannabis Clinician
This article discusses secondhand cannabis smoke exposure in shared residential ventilation systems, relevant to clinicians evaluating patients’ environmental exposure and potential health effects.
SWLA Arrest Report – March 10, 2026
This arrest report documents a marijuana possession charge among other felonies, providing epidemiological data on cannabis use patterns and law enforcement interactions in the Lake Charles population.
New Cannabis Dispensary Opens On Route 22 In Somerville | Bridgewater, NJ Patch
Root 22 Dispensary opened on Route 22 in Somerville, NJ, expanding local cannabis retail access that clinicians may reference when discussing patient sourcing options.
Middle Island man found with over 150 pounds of marijuana in minivan – News12
Cannabis Clinician Summary
Large-scale cannabis possession arrest highlights the distinction between illegal drug trafficking and regulated medical cannabis programs that clinicians operate within.
Tenet Healthcare (THC) CFO logs RSU award, vesting and tax share disposals
This article covers stock transactions by a hospital company executive and has no relevance to cannabis clinicians, as Tenet Healthcare operates traditional medical facilities unrelated to cannabis medicine or practice.
Tenet Healthcare COO reports equity grants and tax trades | THC SEC Filing – Stock Titan
This article covers a healthcare executive’s stock transactions at Tenet Healthcare (THC ticker symbol), which is unrelated to cannabis and not relevant to cannabis clinicians.
Psilocybin could combat post-treatment Lyme disease, new study finds – leafie
Summary
This article discusses research suggesting psilocybin may treat post-treatment Lyme disease symptoms, relevant to clinicians exploring psychedelic-assisted therapies for persistent infection-related conditions.
Buy Recreational Marijuana Products in Columbus, OH | Bloom
This article covers recreational marijuana product availability in Columbus, OH and legal age requirements (21+ for adult use, 18+ for medical), which clinicians need to know for patient referrals and counseling.
Tenet Healthcare (THC) Valuation Check After Strong Recent Share Price Momentum
This article discusses Tenet Healthcare’s stock valuation, not cannabis medicine, so it lacks clinical relevance for cannabis clinicians.
Police: Man charged after feeding parakeet marijuana, beer in Westmoreland County
Cannabis Article Summary for Clinician
This article documents a case of animal abuse involving cannabis and alcohol, which may interest clinicians studying cannabis’s physiological effects on non-human organisms and toxicity concerns.
Bemidji Chamber Ambassadors welcome Coconut Cannabis
Summary for Cannabis Clinician
A cannabis retail business opened in Bemidji with local chamber support, indicating commercial cannabis operations are operating in Minnesota communities.
New Iberia traffic stop uncovers marijuana, THC products – KLFY.com
A traffic stop in New Iberia resulted in arrest for possession of marijuana and THC products, illustrating law enforcement’s continued enforcement of cannabis regulations.
Gainesville man arrested for selling marijuana, methamphetamines, and pills
A Florida arrest for cannabis sales alongside methamphetamine distribution illustrates the enforcement landscape clinicians navigate when distinguishing illicit drug trafficking from legal medical cannabis practice.
BRPD arrest man on various drug and gun charges following the execution of a search warrant
Cannabis Clinician Summary
Law enforcement arrested an individual for marijuana possession along with firearms and cash during a warrant execution, illustrating legal consequences cannabis clinicians should understand when counseling patients.
P640-M worth of marijuana seized at Manila Port, 1 arrested | GMA News Online
Cannabis Clinician Summary
Large-scale cannabis seizure at Manila port highlights law enforcement’s detection capabilities and supply chain vulnerabilities relevant to understanding illicit market operations.
SWLA Arrest Report – March 7, 2026
Summary for Cannabis Clinician
This arrest report documents charges including synthetic marijuana possession, relevant to clinicians assessing patient substance use history and potential legal barriers to cannabis treatment eligibility.
Police Blotter – The Spectator
Cannabis-Related Police Activity Summary
A police report documented a marijuana-related incident among other local matters, providing data on cannabis law enforcement activity in Eau Claire.
How Investors May Respond To Tenet Healthcare (THC) Amid Jobs Report Jitters And …
This article discusses Tenet Healthcare stock movements tied to economic data, which has no direct relevance to cannabis clinical practice or patient care.
Executive Marijuana Supply Chain Jobs in Ohio (NOW HIRING) – ZipRecruiter
Summary
This article lists executive-level supply chain job openings in Ohio’s legal cannabis industry, relevant to clinicians tracking workforce development and operational infrastructure in regulated cannabis markets.
John F. Kennedy Jr. Smoked Marijuana ‘Every Single Day’ Starting at Age 15, Pal Claims in Book
Cannabis Use Pattern in Historical Figure
This article documents a notable public figure’s reported daily cannabis use beginning in adolescence, potentially illustrating early-onset regular use patterns relevant to understanding long-term consumption trajectories.
2 adults arrested after IMPD shuts down underage party on Indy’s west side – WTHR
IMPD shut down an underage party on Indianapolis’s west side where marijuana and alcohol were present, highlighting law enforcement’s role in addressing substance use at youth gatherings.
Former Monroe County commissioner Mark Brant cited for marijuana – Facebook
Former Monroe County official Mark Brant faces marijuana violation citations, relevant to clinicians tracking legal/regulatory enforcement affecting patient access and compliance in Michigan.
Texas man flying to London had 75 pounds of pot in luggage at MIA, police say – NBC 6
A Texas traveler was arrested at Miami International Airport with 75 pounds of cannabis in checked luggage before a London flight, highlighting legal risks of cannabis transportation across jurisdictions.
Notice to proceed for courthouse work received from THC | Refugio County Press
This article covers courthouse restoration in Refugio County and is not relevant to cannabis clinicians, as it addresses construction project updates unrelated to cannabis medicine or practice.
H-E-B unveils inaugural mini market in West Texas school – MySA
Cannabis Article Summary
This article covers H-E-B’s new mini market format in West Texas and mentions legal hemp/THC product retail in San Antonio, relevant to clinicians tracking cannabis market expansion and product availability in their region.
N.Y. cannabis grower to be featured in reality series – Spectrum News
Summary for Cannabis Clinician
This article covers a New York licensed cannabis grower being featured in a reality series, which may increase public visibility of regulated cannabis cultivation practices.
#paulmccartney #marijuana #thebeatles – Instagram
This Instagram post associates Paul McCartney with marijuana and The Beatles, potentially influencing public perception of cannabis use among fans, which is relevant for clinicians understanding cultural attitudes toward the drug.
Swansea cannabis shop CEO says no property auction. ‘I had no idea.’
This article reports a cannabis shop CEO’s denial of property auction rumors, relevant to clinicians monitoring dispensary stability and patient access to cannabis products.
Min Woo Lee’s puppy got high at TPC Sawgrass – Golfweek
Summary for Cannabis Clinician
A golfer’s puppy accidentally ingested THC at a rental property, illustrating unintentional animal exposure risks that clinicians should recognize when counseling patients about home storage safety.
Cannabis Use and Brain Aging: What a Major Study Reveals – Born2Invest
Summary for Cannabis Clinicians
A major study examined cannabis use’s relationship to brain aging markers, providing clinical evidence relevant to assessing long-term neurological effects in patient populations.
Association of Cannabis Use Disorder Versus Other Substance Use Disorders … – Psychiatry Online
This propensity-score-matched study compares cannabis use disorder outcomes with other substance use disorders, providing evidence-based data clinicians need for differential diagnosis and treatment planning.
Cantor Fitzgerald Reiterates Overweight Rating on Tenet Healthcare (THC), Stock a … – StreetInsider
This article does not cover cannabis-related content.
The ticker symbol “THC” refers to Tenet Healthcare Corporation, a hospital operator, not tetrahydrocannabinol or cannabis medicine. The article is about a stock rating and is not relevant to cannabis clinicians.
Hemp THC Drinks Are Exploding. Here’s Why the Alcohol Lobby Is Panicking. | High Times
Hemp-derived THC beverages are rapidly entering mainstream markets, creating competitive pressure on alcohol industries and raising clinical considerations for cannabis practitioners regarding product standardization and patient safety.
Tenet to Participate in the Barclays 28th Annual Global Healthcare Conference – Stock Titan
This article announces Tenet Healthcare’s participation in a Barclays conference; relevant to cannabis clinicians as Tenet operates hospital networks where cannabis-related medical services and research collaborations may develop.
Girl Scout Cookies Strain: Effects, THC Content & Review in 2026 – Herb.co
Cannabis Clinician Summary
This article reviews the Girl Scout Cookies strain’s effects and THC content while citing research linking cannabis use to reported intimacy changes within two hours.
High Tide joins U.S. National Compassionate Care Council | HITI Stock News
High Tide joined a U.S. policy council to modernize medical cannabis regulations and improve patient access to cannabinoid therapies, directly impacting clinical practice standards.
A Prescription Digital Therapeutic Framework for Enhancing Medical Cannabis Care
This article presents a digital therapeutic framework for optimizing medical cannabis treatment delivery using precision medicine principles, helping clinicians personalize cannabinoid therapy and improve patient outcomes.
Wisconsin Governor Pushes To Stop Federal Hemp THC Ban, Saying Lack Of … – Marijuana Moment
Summary
Wisconsin’s governor is challenging federal hemp THC limits, which impacts cannabinoid product regulations and clinical access to hemp-derived compounds for medical practitioners.
Study: Lifetime Cannabis Use Not Associated with Cognitive Decline or Dementia Risk in … – NORML
This study examines cannabis use’s association with cognitive decline and dementia risk, providing clinicians evidence to inform patient counseling about long-term neurological safety concerns.
Cannabis edibles | | wvnews.com
The West Virginia House approved legislation expanding the medical cannabis program to include licensed dispensaries, directly affecting patient access and clinical practice protocols.
D.C. licensed medical cannabis grower closed by law enforcement – Outlaw Report
A licensed D.C. medical cannabis cultivation facility (Blossomz) was shut down by law enforcement, potentially affecting patient access to legally produced medical cannabis products.
Branch County sees decline in marijuana tax revenue for 2025 | WTVB
Cannabis Tax Revenue Decline in Branch County
Branch County local governments are receiving reduced marijuana tax revenue distributions in 2025, affecting public funding streams that support cannabis regulation and healthcare infrastructure.
Nebraska U.S. Senate race filled with alleged ‘plants,’ campaigns say
This article discusses allegations of campaign infiltration in a Nebraska Senate race involving a cannabis-related political party, which has limited direct clinical relevance to cannabis medicine practice.
Digest-Level Clinical Commentary
Clinical Reflection
These items collectively signal that cannabis medicine is entering a critical inflection point where emerging hepatoprotective data on CBD and CBG compounds must be carefully integrated into clinical practice while regulatory fragmentation around potency, delivery methods, and market access continues to create significant obstacles to standardized, evidence-based prescribing. The growing body of clinical trial evidence supporting cannabinoid efficacy for conditions like anxiety and myofascial pain, paired with accelerating state-level legalization, creates both an opportunity and an obligation for clinicians to develop rigorous, personalized dosing protocols while remaining vigilant about the gap between marketed claims and peer-reviewed outcomes. The industry’s expansion into novel delivery systems and dosage forms outpaces our understanding of comparative bioavailability and optimal therapeutic windows, making patient education about potency standards and individual variability more critical
Clinical Perspective
The digest reflects two significant trends in cannabis medicine: emerging preclinical evidence for cannabinoid efficacy in metabolic and pain conditions, and regulatory fragmentation that continues to complicate clinical implementation and patient access. While in vitro and animal studies suggest therapeutic potential for CBD and CBG in hepatic steatosis and CBD in anxiety management, the lack of large-scale human clinical trials limits clinicians’ ability to make evidence-based dosing and indication recommendations. The disparate state-level regulatory approaches to potency and product formulations create inconsistent therapeutic contexts that may impede the development of standardized clinical protocols.
💬 Join the Conversation
Have a question about how this applies to your situation?
Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers?
Join the forum discussion →
Have thoughts on this? Share it: